CBUS — Cibus, Inc.

Nasdaq · Materials · Chemicals · CIK 1705843 ·
Last close
$1.43
Market Cap
$109.15M
52W High
$4.19
52W Low
$1.21
ADV30
379,479
Next earnings
2026-08-13
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 1,681,000 -12,120,000 -21,222,000 324,202,000 30,325,000 288,722,000
Dec 2025 1,057,000 -13,459,000 -31,286,000 305,047,000 9,923,000 283,218,000
Sep 2025 615,000 -15,438,000 -23,541,000 330,226,000 23,886,000 278,197,000
Jun 2025 933,000 -17,946,000 -25,372,000 346,198,000 36,463,000 271,722,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-50,591,000
Investing CF
$-578,000
Financing CF
$46,648,000
CapEx
$-578,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-2.98
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-858,251,000
Inventory
Receivables
$503,000
ST Investments
EBIT TTM
$-96,691,000
Pretax Income TTM
$-132,172,000
Interest Exp TTM
$35,481,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,639,000
EBITDA
$-61,541,000
Free Cash Flow
$-51,790,624
Enterprise Value
$348,688,928
Total Cash
$9,923,000
Total Debt
$267,964,992
Shares Out
76,331,634
Trailing EPS
$-1.77
Book Value
$0.40
ROE
-221.0%
ROA
-12.9%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 3,639,000 -67,464,000 -127,085,000 305,047,000 283,218,000 -50,591,000
Dec 2024 4,262,000 -76,964,000 -251,388,000 350,069,000 252,238,000 -58,043,000
Dec 2023 1,817,000 -69,464,000 -267,627,000 544,411,000 206,117,000 -46,210,000
Dec 2022 157,000 -22,370,000 -16,891,000 22,421,000 15,188,000 -19,364,000
Dec 2021

TTM Snapshot

Revenues TTM
$838,000
NetIncome TTM
$-24,883,000
OpCashFlow TTM
$0
Assets (Latest)
$350,069,000
Forward EPS
$-0.63

Peers — same industry

TickerNameMarket CapLastDaily %
AAWH Ascend Wellness Holdings, Inc. $108.63M $0.54
ARQ Arq, Inc. $106.89M $2.49
JUSHF Jushi Holdings Inc. $97.87M $0.49
LNZA LanzaTech Global, Inc. $95.94M $7.33
FTLF FITLIFE BRANDS, INC. $93.25M $9.93

News headlines (Yahoo Finance, 1h cache)

Cibus, Inc. Q1 2026 Earnings Call Summary
2026-05-15 12:30 · Yahoo
Cibus Inc (CBUS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
2026-05-15 05:02 · Yahoo
Cibus Q1 Earnings Call Highlights
2026-05-14 22:10 · Yahoo
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates
2026-05-14 21:50 · Yahoo
Cibus Reports First Quarter Financial Results and Provides Business Update
2026-05-14 20:05 · Yahoo
Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates
2026-05-12 00:05 · Yahoo
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?
2026-05-06 16:00 · Yahoo
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
2026-05-04 11:00 · Yahoo
Cibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference Call
2026-04-30 20:05 · Yahoo
Cibus Announces the Election of Thomas Urban to Board of Directors
2026-04-15 11:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.